Atherosclerosis: Open Access
Open Access

Different Therapies Practiced in Corneal Regeneration

M Sanjana^* and Shayoli Sarkar

Department of Pharmacy Practice, Jawaharlal Nehru Technological University, Hyderabad, Telangana, India

Received Date: Jul 22, 2022 / Published Date: Jan 17, 2023

Citation: Sanjana M, Sarkar S (2023) Different Therapies Practiced in Corneal Regeneration. Atheroscler Open Access 8:192

Warning: Undefined variable $i in /efsdata/omicsonline.org/httpdocs/peer-reviewed/abstract-page.php on line 156

Warning: Undefined variable $for_cr in /efsdata/omicsonline.org/httpdocs/peer-reviewed/abstract-page.php on line 156
Copyright: © 2023 Sanjana M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

To read the full article Peer-reviewed Article PDF | Peer-reviewed Full Article

The ocular surface is the outermost part of the visual system where physical or chemical action or injury occurs due to some extrinsic or intrinsic factors like thermal injury, infectious pathogens, burns, Steven Johnson Syndrome or other autoimmune diseases. Some limbal cells have the property to be used as stem cells and carry regenerative property due to their ability to differentiate. Corneal wound regeneration is a complex process where the cell undergoes death, proliferation, migration, differentiation and extracellular matrix remodelling. So corneal regeneration can be done using several forms of therapies out of stem cell therapy is best proven type because of the fast recovery from the infections. Although stem cell therapy is still in earlier stages there are interventions to treat corneal abnormalities is going on. In this process there are several viral and non-viral vectors are used to introduce genes into the cornea in vivo, ex vivo, in vitro. This review focusses on the latest process using biological modulators like gene therapy, signalling inhibitors, micro RNA and nano formulations. This paper also focusses on the latest therapies using stem cells and improvement in ocular drug delivery system to improve the possible and potential therapy of current knowledge for the future treatment of ocular disease.

Keywords